Altamira Therapeutics Ltd. Number Of Instruments Granted In Share-based Payment Arrangement
Altamira Therapeutics Ltd. (CYTOF) reported Number Of Instruments Granted In Share-based Payment Arrangement of 2535000.00% for the 6-month period ending 2024-06-30, per its 6-K filed 2025-08-29.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement · last filed 2025-08-29
- 2024-06-30: Number Of Instruments Granted In Share-based Payment Arrangement 6 month 2535000.00%.
| Period end | Number Of Instruments Granted In Share-based Payment Arrangement 6 month |
|---|---|
| 2024-06-30 | 2535000.00% 6-K · filed 2025-08-29 |